Wahl, Sharon M; Redford, Maryann; Christensen, Shawna et al. (2011) Systemic and mucosal differences in HIV burden, immune, and therapeutic responses. J Acquir Immune Defic Syndr 56:401-11
|
Cohn, Jonathan A; Hashemi, Farhad B; Camarca, Margaret et al. (2005) HIV-inducing factor in cervicovaginal secretions is associated with bacterial vaginosis in HIV-1-infected women. J Acquir Immune Defic Syndr 39:340-6
|
Lurain, Nell S; Robert, Emmanuel S; Xu, Jiahong et al. (2004) HIV type 1 and cytomegalovirus coinfection in the female genital tract. J Infect Dis 190:619-23
|
Nag, Pratip; Kim, Jenney; Sapiega, Vytautas et al. (2004) Women with cervicovaginal antibody-dependent cell-mediated cytotoxicity have lower genital HIV-1 RNA loads. J Infect Dis 190:1970-8
|
Hafner, R; Bethel, J; Standiford, H C et al. (2001) Tolerance and pharmacokinetic interactions of rifabutin and azithromycin. Antimicrob Agents Chemother 45:1572-7
|
Kovacs, A; Wasserman, S S; Burns, D et al. (2001) Determinants of HIV-1 shedding in the genital tract of women. Lancet 358:1593-601
|
Landay, A L; Bethel, J; Schnittman, S (1998) Phenotypic variability of lymphocyte populations in peripheral blood and lymph nodes from HIV-infected individuals and the impact of antiretroviral therapy. DATRI 003 Study Group. Division of AIDS Treatment Research Initiative. AIDS Res Hum Retroviruses 14:445-51
|
Hafner, R; Bethel, J; Power, M et al. (1998) Tolerance and pharmacokinetic interactions of rifabutin and clarithromycin in human immunodeficiency virus-infected volunteers. Antimicrob Agents Chemother 42:631-9
|
Bartlett, J A; Wasserman, S S; Hicks, C B et al. (1998) Safety and immunogenicity of an HLA-based HIV envelope polyvalent synthetic peptide immunogen. DATRI 010 Study Group. Division of AIDS Treatment Research Initiative. AIDS 12:1291-300
|
Timpone, J G; Wright, D J; Li, N et al. (1997) The safety and pharmacokinetics of single-agent and combination therapy with megestrol acetate and dronabinol for the treatment of HIV wasting syndrome. The DATRI 004 Study Group. Division of AIDS Treatment Research Initiative. AIDS Res Hum Retroviruses 13:305-15
|
Showing the most recent 10 out of 13 publications